INTERvention With Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation (INTERCEPTavi)
INTERCEPTavi
1 other identifier
interventional
120
1 country
1
Brief Summary
The study aims to evaluate the processes of a pilot single-centre randomised controlled trial (RCT) of carbon-dioxide flushing of transcatheter aortic valves (TAVI-CO2) versus standard saline flushing of valves (TAVI-S) and assess potential neuroprotection through a number of neurological endpoints for planning of a full-sized RCT
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Sep 2021
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 11, 2021
CompletedFirst Posted
Study publicly available on registry
December 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJanuary 26, 2023
January 1, 2023
2.2 years
November 11, 2021
January 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants suitable for recruitment for larger RCT
Conduct an evaluation of the processes described in this pilot RCT for a full-scale RCT including: 1. Screening, Recruitment and Randomisation 2. Retention in follow-up assessments 3. Study design for a full RCT and identification of important stratification variables 4. Refine sample size calculation for a full RCT
Duration of study, approximately 15 months
Secondary Outcomes (1)
Incidence of Vascular Brain Injury (VBI) on Diffusion Weighted-Magnetic Resonance Imaging (DW-MRI)
Post TAVI 1-7 days and 6-months post TAVI
Other Outcomes (4)
Detection of periprocedural cerebral solid and gaseous emboli
During TAVI procedure
Neurological deficit
6 Months
Inflammatory biomarker assessing brain injury
24 hours post TAVI
- +1 more other outcomes
Study Arms (2)
Saline flushing
ACTIVE COMPARATORTAVI valves will be prepared according to instruction for use(IFU) with saline flushing only.
CO2 and saline flushing
EXPERIMENTALTAVI valves will be flushed with CO2 and then saline as per IFU
Interventions
TAVI valves will be prepared by flushing with CO2 to displace any retained air during manufacturing and preparation. The valves will then be flushed with saline as per IFU.
Eligibility Criteria
You may qualify if:
- All patients between the ages of 18 and 100 years undergoing transcatheter aortic valve implantation (TAVI) for aortic stenosis under local anaesthetic.
You may not qualify if:
- Patients that lack capacity to provide informed consent
- Patients that have had a stroke within 12 months
- Patients aged less than 18 years of age
- Patients that are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Imperial College Londonlead
- Imperial College Healthcare NHS Trustcollaborator
Study Sites (1)
Imperial College London
London, United Kingdom
Related Publications (5)
Inci K, Koutouzi G, Chernoray V, Jeppsson A, Nilsson H, Falkenberg M. Air bubbles are released by thoracic endograft deployment: An in vitro experimental study. SAGE Open Med. 2016 Dec 7;4:2050312116682130. doi: 10.1177/2050312116682130. eCollection 2016.
PMID: 27994872BACKGROUNDRohlffs F, Tsilimparis N, Saleptsis V, Diener H, Debus ES, Kolbel T. Air Embolism During TEVAR: Carbon Dioxide Flushing Decreases the Amount of Gas Released from Thoracic Stent-Grafts During Deployment. J Endovasc Ther. 2017 Feb;24(1):84-88. doi: 10.1177/1526602816675621. Epub 2016 Oct 26.
PMID: 27798380BACKGROUNDMartens S, Neumann K, Sodemann C, Deschka H, Wimmer-Greinecker G, Moritz A. Carbon dioxide field flooding reduces neurologic impairment after open heart surgery. Ann Thorac Surg. 2008 Feb;85(2):543-7. doi: 10.1016/j.athoracsur.2007.08.047.
PMID: 18222261BACKGROUNDBismuth J, Garami Z, Anaya-Ayala JE, Naoum JJ, El Sayed HF, Peden EK, Lumsden AB, Davies MG. Transcranial Doppler findings during thoracic endovascular aortic repair. J Vasc Surg. 2011 Aug;54(2):364-9. doi: 10.1016/j.jvs.2010.12.063. Epub 2011 Mar 3.
PMID: 21371850BACKGROUNDPerera AH, Rudarakanchana N, Monzon L, Bicknell CD, Modarai B, Kirmi O, Athanasiou T, Hamady M, Gibbs RG. Cerebral embolization, silent cerebral infarction and neurocognitive decline after thoracic endovascular aortic repair. Br J Surg. 2018 Mar;105(4):366-378. doi: 10.1002/bjs.10718. Epub 2018 Feb 12.
PMID: 29431856BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ghada Mikhail
Imperial College London
Central Study Contacts
Ghada Mikhail, MD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients and outcome assessors will be blinded to intervention.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2021
First Posted
December 6, 2021
Study Start
September 1, 2021
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
January 26, 2023
Record last verified: 2023-01